Yaremchuk M J, Sedacca T, Schiller A L, May J W
Plast Reconstr Surg. 1983 Apr;71(4):461-72.
Using a rabbit model in which vascularized knee autograft transplantation was successful, vascularized knee allograft transplants survived an average of 9 days, as determined by serial bone scan. The longest surviving allograft was one of 3 months. Immunosuppression and irradiation did not significantly increase survival. Both vascularized and nonvascularized allografts elicited a second-set skin graft response but no histologic evidence of rejection. This suggests that joint allografts are clearly immunogenic but do not undergo the same destructive rejection process with a clear end point seen with soft-tissue grafts. Donor vessels did show a classic rejection picture with severe intimal damage presumably predisposing to vessel thrombosis and graft loss. Vascular rejection, therefore, limited joint allograft survival. Immediate vascularization of the allograft with subsequent limited survival does not enhance host revascularization and creeping substitution at 1, 3, or 6 months. These findings do not suggest clinical applicability for vascularized joint allograft transplantation at this time. Future experimental studies should employ genetically defined models.
在一个成功进行血管化膝关节自体移植的兔模型中,通过系列骨扫描确定,血管化膝关节同种异体移植平均存活9天。存活时间最长的同种异体移植为3个月。免疫抑制和照射并未显著提高存活率。血管化和非血管化同种异体移植均引发二次皮肤移植反应,但无排斥反应的组织学证据。这表明关节同种异体移植显然具有免疫原性,但不会经历与软组织移植中明显终点的相同破坏性排斥过程。供体血管确实显示出典型的排斥反应,伴有严重的内膜损伤,可能易导致血管血栓形成和移植物丢失。因此,血管排斥限制了关节同种异体移植的存活。同种异体移植的即刻血管化以及随后有限的存活时间,在1、3或6个月时并未增强宿主血管再生和爬行替代。这些发现目前并不表明血管化关节同种异体移植具有临床适用性。未来的实验研究应采用基因定义的模型。